Skip to main content
. 2019 Sep 13;11:8391–8405. doi: 10.2147/CMAR.S217375

Table 3.

Correlation of base excision repair (BER) system genes expression with overall survival (OS) in gastric cancer patients with HER2 expression status

BER system HER 2 status Cases HR (95% CI) P-value
UNG Negative 298 1.42 (1.08−1.88) 0.013*
Positive 295 1.48 (1.13−1.94) 0.0044*
SMUG1 Negative 532 1.64 (1.3−2.09) 3.6e−05*
Positive 344 1.47 (1.12−1.93) 0.0054*
MBD4 Negative 532 1.29 (1.01−1.66) 0.041*
Positive 344 1.75 (1.31−2.35) 0.00014*
TDG Negative 532 2.05 (1.64−2.57) 2.1e−10*
Positive 344 2.44 (1.87−3.18) 9.9e−12*
OGG1 Negative 532 2.05 (1.6−2.63) 7.2e−09*
Positive 344 1.68 (1.25−2.27) 0.00052*
MUTYH Negative 532 1.46 (1.16−1.85) 0.0014*
Positive 344 1.29 (0.99−1.67) 0.057
NEIL1 Negative 532 2.02 (1.57−2.59) 2.5e−08*
Positive 344 1.62 (1.23−2.14) 0.00055*

Note: *P<0.05.

Abbreviations: CI, confidence interval; HR, hazard ratio; HER2, human epidermal growth factor receptor-2; UNG, uracil-DNA glycosylase; SMUG1, single-strand-selective monofunctional uracil-DNA glycosylase 1; MBD4, Methyl-CpG binding domain 4; TDG, thymine DNA glycosylase; OGG1, 8-oxoguanine DNA glycosylase; MUTYH, MutY DNA glycosylase; NEIL1, Nei like DNA glycosylase 1.